Related Experiment Videos
Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with
Insights
Beta-blockers and calcium-entry blockers are effective monotherapy for angina. Combining these drugs for exertional angina is safe, well-tolerated, and improves exercise tolerance without adverse effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Beta-blockers and calcium-entry blockers are established antianginal monotherapies.
- Different drug classes exhibit distinct mechanisms affecting heart rate and rate-pressure product during exercise.
Purpose of the Study:
- To evaluate the efficacy and safety of combination therapy with beta-blockers and calcium-entry blockers in patients with exertional angina.
- To assess symptom alleviation and exercise tolerance in patients with persistent angina despite beta-blockade.
Main Methods:
- Investigated the effects of adding calcium-entry blockers to beta-blocker therapy.
- Monitored patient response, exercise tolerance, and adverse clinical effects.
- Assessed left ventricular function in patients receiving combination therapy.
Main Results:
- Combination therapy demonstrated further symptom alleviation and increased exercise tolerance.
- Individual patient responses to different calcium-entry blockers varied when combined with propranolol.
- No deleterious effects on left ventricular function or increased adverse events were observed.
Conclusions:
- Combination therapy with beta-blockers and calcium-entry blockers is well-tolerated, effective, and safe for exertional angina.
- This combination offers short-term and long-term benefits for patients with persistent anginal symptoms.
Abstract:
For monotherapy, beta-blockers and calcium-entry blockers are effective and safe antianginal medications. For prophylaxis of myocardial ischemia, a different mechanism of action for each class of drugs is reflected by the different heart rate and rate-pressure product during exercise. In patients who continue to have anginal symptoms despite adequate beta-blockade, further alleviation of symptoms together with an increase in exercise tolerance may be observed with the addition of a calcium-entry blocker. Of note is the individual patient response to the various calcium-entry blockers when combined with propranolol. Although of theoretic concern with combination therapy, no deleterious effect on left ventricular function or increased adverse clinical effects were noted in our studies. Combination therapy with beta-blockers and calcium-entry blockers is well tolerated, effective, and safe both over the short and long term in patients with exertional angina.